Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Marinus Pharmaceuticals I...

    NASDAQ: MRNS · Real-Time Price · USD
    0.55
    0.00 (0.00%)
    At close: Feb 10, 2025, 3:59 PM

    Marinus Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 30.99M 25.48M 15.35M
    Cost of Revenue
    		 1.93M 340K 1.48M
    Gross Profit
    		 29.05M 25.14M 13.87M
    Operating Income
    		 -131.49M -112.79M -96.93M
    Interest Income
    		 8.11M 2.35M 80K
    Pretax Income
    		 -142.94M -16.43M -98.78M
    Net Income
    		 -141.41M -19.82M -101.66M
    Selling & General & Admin
    		 61.15M 56.84M 37.28M
    Research & Development
    		 99.39M 79.91M 73.52M
    Other Expenses
    		 n/a 1.17M 657K
    Operating Expenses
    		 160.54M 137.93M 110.8M
    Interest Expense
    		 16.89M 10.67M 2.58M
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 162.47M 138.27M 112.28M
    Income Tax Expense
    		 -1.54M 3.39M 2.88M
    Shares Outstanding (Basic)
    		 53.75M 39.07M 36.7M
    Shares Outstanding (Diluted)
    		 53.75M 39.07M 36.7M
    EPS (Basic)
    		 -2.63 -0.51 -2.77
    EPS (Diluted)
    		 -2.63 -0.51 -2.77
    EBITDA
    		 -125.5M -5.09M -95.53M
    EBIT
    		 -126.05M -5.75M -96.19M
    Depreciation & Amortization
    		 551K 669K 667K

    Add to Watchlist